Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Breast Cancer
- 1 January 1988
- book chapter
- Published by Springer Nature
- Vol. 39, 39-49
- https://doi.org/10.1007/978-1-4613-1731-9_3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinomaBreast Cancer Research and Treatment, 1986
- Remissions of metastatic breast cancer in post-menopausal women with luteinising hormone releasing hormone (ICI 118630) therapyEuropean Journal of Cancer and Clinical Oncology, 1986
- Phase II trial of D-Trp-6-LH-RH in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Autocrine and paracrine growth regulation of human breast cancerJournal of Steroid Biochemistry, 1986
- LHRH-Agonist treatment in clinical and experimental human breast cancerJournal of Steroid Biochemistry, 1985
- Gonadotropin-Releasing Hormone Binding Sites in Human Breast CarcinomaScience, 1985
- Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistNature, 1985
- Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancerBreast Cancer Research and Treatment, 1984
- Endocrine-Dependent Rat Mammary Tumor Regression: Use of a Gonadotropin Releasing Hormone AnalogScience, 1976
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896